← Open Payments lookup

MOHAMMED LATIF: Open Payments

NPI 1437121498 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$400 in 15 payments from 9 companies in 2025. Trend: 2023 $92 · 2024 $341 · 2025 $400

Food & beverage: $400
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$129
ABBVIE INC.3$56
Alkermes, Inc.2$42
E.R. Squibb & Sons, L.L.C.2$41
Lundbeck LLC2$41
Otsuka Pharmaceutical Development & Commercialization, Inc.1$24
Janssen Pharmaceuticals, Inc1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Otsuka America Pharmaceutical, Inc.1$20

Products named: UZEDY, VRAYLAR, COBENFY, REXULTI, LYBALVI, ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA.

Industry payments across MD — which companies pay providers there.